Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.

about

Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.

Item

http://www.wikidata.org/entity/Q48192268

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@en

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@nl

type

Item

label

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@en

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@nl

prefLabel

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@en

Detrimental roles of TNF-alpha ...... maceuticals against TNF-alpha.

@nl

P1476

Detrimental roles of TNF-alpha ...... rmaceuticals against TNF-alpha

@en

P2093

Mirjana Bećarević

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data.

Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.

Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.

Endothelial cell activation by antiphospholipid antibodies.

Antiphospholipid syndrome and tissue factor: a thrombotic couple.

P2888

s11239-017-1571-4

P304

565-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-017-1571-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mirjana Becarevic

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29027631

http://www.w3.org/2001/XMLSchema#string

P921

TNF